The healthcare landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential advance. Unlike subcutaneous injections, this technique offers a more convenient way to deliver GLP-1 drugs. These transdermal systems slowly release the treatment through the surface o